View ValuationThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsMusclePharm 将来の成長Future 基準チェック /06現在、 MusclePharmの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Personal Products 収益成長33.9%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesお知らせ • Sep 29FitLife Brands, Inc. (NasdaqCM:FTLF) entered into an agreement to acquire Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q) for $18.3 million.FitLife Brands, Inc. (NasdaqCM:FTLF) entered into an agreement to acquire Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q) for $18.3 million on September 5, 2023. The Purchase Price is subject to adjustment and is expected to be funded from available cash and the proceeds from a committed $10.0 million term loan from First Citizens Bank with an interest rate equal to the SOFR (secured overnight financing rate) plus 275 basis points. On September 21, 2023, the U.S. Bankruptcy Court for the District of Nevada approved the transaction. Closing of the sale will occur on or before October 16, 2023. Samuel A. Schwartz of Schwartz Law, PLLC acted as legal advisor to MusclePharm. Todd Feinsmith of Troutman Pepper Hamilton Sanders LLP acted as legal advisor to FitLife Brands.お知らせ • Sep 01Musclepharm Corporation Announces Resignation of Paul Karr as DirectorEffective as of August 9, 2023, Paul Karr resigned as director MusclePharm Corporation. Mr. Karr’s resignation from the Board of Directors of the Company did not result from any disagreement with the Company.お知らせ • Jul 22Musclepharm Corporation Terminates Gary Shirshac as Chief Financial OfficerEffective as of July 10, 2023, MusclePharm Corporation terminated Chief Financial Officer, Gary Shirshac. There are no family relationships between Mr. Shirshac and any other director or officer of the Company. There are no transactions in which Mr. Shirshac has an interest requiring disclosure under Item 404(a) of Regulation S-K. Separately, on December 15, 2022, the Company filed for protection under Chapter 11 of the United States Bankruptcy Code before the United States Bankruptcy Court for the District of Nevada, Case No. 22-14422 – NMC. Attached hereto are copies of the Monthly Operating Reports filed in the bankruptcy case.お知らせ • Dec 16MusclePharm Corporation Filed for BankruptcyMusclePharm Corporation filed a voluntary petition for reorganization under Chapter 11 in the US Bankruptcy Court for the District of Nevada on December 15, 2022. The debtor listed both its assets and liabilities in the range of $10 million to $50 million. The debtor is represented by Samuel A. Schwartz of Schwartz Law, PLLC as its legal counsel.お知らせ • Sep 30MusclePharm Corporation Appoints Gary C. Shirshac to Serve as Interim Chief Financial OfficerOn September 26, 2022, MusclePharm Corporation appointed Gary C. Shirshac to serve as interim chief financial officer. There are no family relationships between Mr. Shirshac and any other director or officer of the company. There are no transactions in which Mr. Shirshac has an interest requiring disclosure under Item 404(a) of Regulation S-K. Set forth below is the biographical information of Mr. Shirshac, as required by Item 401 of Regulation S-K. Mr. Shirshac’s base salary is $250,000 and he will be eligible to participate in the company’s benefits plan as of October 1, 2022. Prior to joining the company, Mr. Shirshac, 60, served as the chief financial officer and on the board of Directors of Newpoint Financial Corporation from 2020 to February 2022. Prior to that, Mr. Shirshac served as the Chief Financial Officer and Managing Director of GCS Consulting from 2013 to 2019. Mr. Shirshac’s work experience prior to that included accounting, tax and SEC compliance work in-house, as a consultant and in national accounting firms. Mr. Shirshac is a Certified Public Accountant and received his BS Accountancy from Villanova University.お知らせ • Aug 18MusclePharm Corporation announced delayed 10-Q filingOn 08/17/2022, MusclePharm Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Jul 29+ 1 more updateMusclePharm Corporation Announces Appointment of Eric Chin as Chief Financial Officer of the CompanyMusclePharm Corporation announced that on July 28, 2022, the Board of Directors appointed Eric Chin as Chief Financial Officer of the Company. There are no family relationships between Mr. Chin and any other director or officer of the Company. Mr. Chin, joined the Company in June 2022 as Chief Accounting Officer. Prior to that, Mr. Chin served as the Chief Financial Officer of Apollo Medical Holdings Inc. from 2018 to May 2022. Prior to that, Mr. Chin served as the Controller/Head of Finance - Real Estate of Public Storage from 2015 to 2018. Mr. Chin served as Assistant Vice-President - Financial Reporting of Alexandria Real Estate Equities Inc. from 2011 to 2015. Mr. Chin began his career at Ernst & Young, LLP in 2002. Mr. Chin is a Certified Public Accountant and received his Bachelor of Arts in Business/Economics with Accounting and Computing from UCLA.お知らせ • Jul 13+ 1 more updateSabina Rizvi Notifies MusclePharm Corporation of Her Resignation as President, Effective July 22, 2022On July 6, 2022, Sabina Rizvi notified the Board of Directors of MusclePharm Corporation of her resignation as President of the Company, effective July 22, 2022.お知らせ • Jul 07MusclePharm Announces the Launch of FitMiss EnergyMusclePharm Corporation announced the launch of FitMiss Energy, a ready-to-drink, zero-calorie functional energy beverage featuring 450mg of Branched Chain Amino Acids (“BCAA”), 200mg of caffeine, and 100% recommended dietary intake (“RDI”) of Biotin per can in three refreshing flavors: Pineapple Coco, Mango Sunshine, and Watermelon Waterfall. The MusclePharm FitMiss brand has been a leader in the female performance segment, with FitMiss Delight, for the last 5 years. Building onto the FitMiss brand family, FitMiss Energy features no artificial colorings or flavorings and is available in competitively priced, 12-can cases of a single flavor or a variety-pack format exclusively on Amazon.お知らせ • Jun 24Musclepharm Corporation Appoints Eric Chin as Chief Accounting OfficerMusclePharm Corporation announced that effective as of June 17, 2022 the company appointed Mr. Eric Chin as the Company’s Chief Accounting Officer. Mr. Chin, age 42, joins the Company from Apollo Medical Holdings Inc., where he served as Chief Financial Officer. From 2015 to 2018, Mr. Chin served as the Controller/Head of Finance - Real Estate of Public Storage. From 2011 to 2015, he served as Assistant Vice-President - Financial Reporting of Alexandria Real Estate Equities Inc. Mr. Chin began his career at Ernst & Young, LLP in 2002. Mr. Chin is a Certified Public Accountant. He received his Bachelor of Arts in Business/Economics with Accounting and Computing from UCLA.お知らせ • Jun 15MusclePharm Corporation Appoints Sabina Rizvi as Member of the Board of DirectorsMusclePharm Corporation announced that effective June 10, 2022, the company appointed Sabina Rizvi, the Company’s President and Chief Financial Officer, as a member of the board of directors of the Company. Sabina Rizvi has served as the Company’s President and Chief Financial Officer since April 2021. Previously, Ms. Rizvi held multiple C-suite roles at Yum! Brands, with increasing responsibility including CFO of the Canadian and Thailand business units and President and General Manager of Pizza Hut Thailand, where she oversaw significant growth of the brand. Most recently, she was Chief Operating Officer, Yum! Digital and Technology, playing an instrumental role in leveraging technology to transform the customer experience. Ms. Rizvi graduated from University of Windsor, Canada with a Master of Business Administration and completed her Honors Bachelor of Mathematics from University of Waterloo, Canada. The Company believes Ms. Rizvi is qualified to serve as a member of the Company’s board of directors because of the aforementioned experience and the breadth of her management responsibilities with the Company.お知らせ • May 12MusclePharm Corporation to Report Q1, 2022 Results on May 16, 2022MusclePharm Corporation announced that they will report Q1, 2022 results After-Market on May 16, 2022お知らせ • Apr 13MusclePharm Corporation to Report Q4, 2021 Results on Apr 14, 2022MusclePharm Corporation announced that they will report Q4, 2021 results After-Market on Apr 14, 2022お知らせ • Apr 01+ 1 more updateMusclePharm Corporation announced delayed annual 10-K filingOn 03/31/2022, MusclePharm Corporation announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Feb 08MusclePharm Rolls Out New and Improved MP Combat Protein Powder to Costco USMusclePharm Corporation announced the expansion of its product line with Costco U.S with the roll out of its reformulated MP Combat Protein Powder in a newly sized tub. The reformulated product has an improved taste and mixability factor and is now being sold in Costco U.S in a recyclable, 6.2-liter tub. The new product will be part of a promotion running in all Costco U.S stores this March with samples available for customers to try out the new taste.お知らせ • May 18MusclePharm Corporation announced delayed 10-Q filingOn 05/17/2021, MusclePharm Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Jan 22Musclepharm Appoints Michael Heller to Its Board of DirectorsMusclePharm Corporation announced that it has appointed Michael Heller to its Board of Directors. Michael Heller, Principal of Talent Resources Holdings, is a marketing visionary in the world of influencer, celebrity, athlete and social media marketing. He has become a leading industry voice, having appeared in such major outlets as CNBC, Business Insider, Fortune, Fox Business, Buzzfeed, CNN, Digiday, The Hollywood Reporter, Vanity Fair and many others. With over 25 years of experience, Michael has conceived and produced some of the most high-profile events and activations in the country, including the annual Sports Illustrated Super Bowl party.お知らせ • Jan 09William Bush Submits Resignation from the Board of Directors of MusclePharm Corporation and All CommitteesOn December 31, 2020, William Bush submitted his resignation from the Board of Directors of MusclePharm Corporation and all committees on which he served, effective the date thereof. このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、MusclePharm は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測OTCPK:MSLP.Q - アナリストの将来予測と過去の財務データ ( )USD Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数3/31/202250-19-12-12N/A12/31/202150-13-8-8N/A9/30/202155-3-6-6N/A6/30/2021591-3-3N/A3/31/2021613-1-1N/A12/31/2020643-1-1N/A9/30/202067-300N/A6/30/202072-900N/A3/31/202077-14-2-2N/A12/31/201980-19-7-7N/A9/30/201982-22-4-4N/A6/30/201983-18-3-3N/A3/31/201983-13-3-3N/A12/31/201888-1122N/A9/30/201894-7-1-1N/A6/30/201896-7-3-3N/A3/31/2018100-10-4-4N/A12/31/2017102-11-5-5N/A9/30/20171030-17-17N/A6/30/20171091-16-16N/A3/31/20171160-19-18N/A12/31/2016132-3-16-15N/A9/30/2016148-22-4-3N/A6/30/2016151-48-11N/A3/31/2016168-5167N/A12/31/2015167-52N/A5N/A9/30/2015158-58N/A9N/A6/30/2015172-30N/A0N/A3/31/2015169-24N/A-3N/A12/31/2014177-14N/A-4N/A9/30/2014182-2N/A-8N/A6/30/2014160-6N/A-5N/A3/31/2014139-8N/A-8N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: MSLP.Qの予測収益成長が 貯蓄率 ( 2.8% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: MSLP.Qの収益がUS市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: MSLP.Qの収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: MSLP.Qの収益がUS市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: MSLP.Qの収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: MSLP.Qの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YHousehold 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2025/03/08 05:38終値2025/03/05 00:00収益2022/03/31年間収益2021/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋MusclePharm Corporation 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。2 アナリスト機関Edward WooAscendiant Capital Markets LLCJack WallaceSidoti & Company, LLC
お知らせ • Sep 29FitLife Brands, Inc. (NasdaqCM:FTLF) entered into an agreement to acquire Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q) for $18.3 million.FitLife Brands, Inc. (NasdaqCM:FTLF) entered into an agreement to acquire Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q) for $18.3 million on September 5, 2023. The Purchase Price is subject to adjustment and is expected to be funded from available cash and the proceeds from a committed $10.0 million term loan from First Citizens Bank with an interest rate equal to the SOFR (secured overnight financing rate) plus 275 basis points. On September 21, 2023, the U.S. Bankruptcy Court for the District of Nevada approved the transaction. Closing of the sale will occur on or before October 16, 2023. Samuel A. Schwartz of Schwartz Law, PLLC acted as legal advisor to MusclePharm. Todd Feinsmith of Troutman Pepper Hamilton Sanders LLP acted as legal advisor to FitLife Brands.
お知らせ • Sep 01Musclepharm Corporation Announces Resignation of Paul Karr as DirectorEffective as of August 9, 2023, Paul Karr resigned as director MusclePharm Corporation. Mr. Karr’s resignation from the Board of Directors of the Company did not result from any disagreement with the Company.
お知らせ • Jul 22Musclepharm Corporation Terminates Gary Shirshac as Chief Financial OfficerEffective as of July 10, 2023, MusclePharm Corporation terminated Chief Financial Officer, Gary Shirshac. There are no family relationships between Mr. Shirshac and any other director or officer of the Company. There are no transactions in which Mr. Shirshac has an interest requiring disclosure under Item 404(a) of Regulation S-K. Separately, on December 15, 2022, the Company filed for protection under Chapter 11 of the United States Bankruptcy Code before the United States Bankruptcy Court for the District of Nevada, Case No. 22-14422 – NMC. Attached hereto are copies of the Monthly Operating Reports filed in the bankruptcy case.
お知らせ • Dec 16MusclePharm Corporation Filed for BankruptcyMusclePharm Corporation filed a voluntary petition for reorganization under Chapter 11 in the US Bankruptcy Court for the District of Nevada on December 15, 2022. The debtor listed both its assets and liabilities in the range of $10 million to $50 million. The debtor is represented by Samuel A. Schwartz of Schwartz Law, PLLC as its legal counsel.
お知らせ • Sep 30MusclePharm Corporation Appoints Gary C. Shirshac to Serve as Interim Chief Financial OfficerOn September 26, 2022, MusclePharm Corporation appointed Gary C. Shirshac to serve as interim chief financial officer. There are no family relationships between Mr. Shirshac and any other director or officer of the company. There are no transactions in which Mr. Shirshac has an interest requiring disclosure under Item 404(a) of Regulation S-K. Set forth below is the biographical information of Mr. Shirshac, as required by Item 401 of Regulation S-K. Mr. Shirshac’s base salary is $250,000 and he will be eligible to participate in the company’s benefits plan as of October 1, 2022. Prior to joining the company, Mr. Shirshac, 60, served as the chief financial officer and on the board of Directors of Newpoint Financial Corporation from 2020 to February 2022. Prior to that, Mr. Shirshac served as the Chief Financial Officer and Managing Director of GCS Consulting from 2013 to 2019. Mr. Shirshac’s work experience prior to that included accounting, tax and SEC compliance work in-house, as a consultant and in national accounting firms. Mr. Shirshac is a Certified Public Accountant and received his BS Accountancy from Villanova University.
お知らせ • Aug 18MusclePharm Corporation announced delayed 10-Q filingOn 08/17/2022, MusclePharm Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Jul 29+ 1 more updateMusclePharm Corporation Announces Appointment of Eric Chin as Chief Financial Officer of the CompanyMusclePharm Corporation announced that on July 28, 2022, the Board of Directors appointed Eric Chin as Chief Financial Officer of the Company. There are no family relationships between Mr. Chin and any other director or officer of the Company. Mr. Chin, joined the Company in June 2022 as Chief Accounting Officer. Prior to that, Mr. Chin served as the Chief Financial Officer of Apollo Medical Holdings Inc. from 2018 to May 2022. Prior to that, Mr. Chin served as the Controller/Head of Finance - Real Estate of Public Storage from 2015 to 2018. Mr. Chin served as Assistant Vice-President - Financial Reporting of Alexandria Real Estate Equities Inc. from 2011 to 2015. Mr. Chin began his career at Ernst & Young, LLP in 2002. Mr. Chin is a Certified Public Accountant and received his Bachelor of Arts in Business/Economics with Accounting and Computing from UCLA.
お知らせ • Jul 13+ 1 more updateSabina Rizvi Notifies MusclePharm Corporation of Her Resignation as President, Effective July 22, 2022On July 6, 2022, Sabina Rizvi notified the Board of Directors of MusclePharm Corporation of her resignation as President of the Company, effective July 22, 2022.
お知らせ • Jul 07MusclePharm Announces the Launch of FitMiss EnergyMusclePharm Corporation announced the launch of FitMiss Energy, a ready-to-drink, zero-calorie functional energy beverage featuring 450mg of Branched Chain Amino Acids (“BCAA”), 200mg of caffeine, and 100% recommended dietary intake (“RDI”) of Biotin per can in three refreshing flavors: Pineapple Coco, Mango Sunshine, and Watermelon Waterfall. The MusclePharm FitMiss brand has been a leader in the female performance segment, with FitMiss Delight, for the last 5 years. Building onto the FitMiss brand family, FitMiss Energy features no artificial colorings or flavorings and is available in competitively priced, 12-can cases of a single flavor or a variety-pack format exclusively on Amazon.
お知らせ • Jun 24Musclepharm Corporation Appoints Eric Chin as Chief Accounting OfficerMusclePharm Corporation announced that effective as of June 17, 2022 the company appointed Mr. Eric Chin as the Company’s Chief Accounting Officer. Mr. Chin, age 42, joins the Company from Apollo Medical Holdings Inc., where he served as Chief Financial Officer. From 2015 to 2018, Mr. Chin served as the Controller/Head of Finance - Real Estate of Public Storage. From 2011 to 2015, he served as Assistant Vice-President - Financial Reporting of Alexandria Real Estate Equities Inc. Mr. Chin began his career at Ernst & Young, LLP in 2002. Mr. Chin is a Certified Public Accountant. He received his Bachelor of Arts in Business/Economics with Accounting and Computing from UCLA.
お知らせ • Jun 15MusclePharm Corporation Appoints Sabina Rizvi as Member of the Board of DirectorsMusclePharm Corporation announced that effective June 10, 2022, the company appointed Sabina Rizvi, the Company’s President and Chief Financial Officer, as a member of the board of directors of the Company. Sabina Rizvi has served as the Company’s President and Chief Financial Officer since April 2021. Previously, Ms. Rizvi held multiple C-suite roles at Yum! Brands, with increasing responsibility including CFO of the Canadian and Thailand business units and President and General Manager of Pizza Hut Thailand, where she oversaw significant growth of the brand. Most recently, she was Chief Operating Officer, Yum! Digital and Technology, playing an instrumental role in leveraging technology to transform the customer experience. Ms. Rizvi graduated from University of Windsor, Canada with a Master of Business Administration and completed her Honors Bachelor of Mathematics from University of Waterloo, Canada. The Company believes Ms. Rizvi is qualified to serve as a member of the Company’s board of directors because of the aforementioned experience and the breadth of her management responsibilities with the Company.
お知らせ • May 12MusclePharm Corporation to Report Q1, 2022 Results on May 16, 2022MusclePharm Corporation announced that they will report Q1, 2022 results After-Market on May 16, 2022
お知らせ • Apr 13MusclePharm Corporation to Report Q4, 2021 Results on Apr 14, 2022MusclePharm Corporation announced that they will report Q4, 2021 results After-Market on Apr 14, 2022
お知らせ • Apr 01+ 1 more updateMusclePharm Corporation announced delayed annual 10-K filingOn 03/31/2022, MusclePharm Corporation announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Feb 08MusclePharm Rolls Out New and Improved MP Combat Protein Powder to Costco USMusclePharm Corporation announced the expansion of its product line with Costco U.S with the roll out of its reformulated MP Combat Protein Powder in a newly sized tub. The reformulated product has an improved taste and mixability factor and is now being sold in Costco U.S in a recyclable, 6.2-liter tub. The new product will be part of a promotion running in all Costco U.S stores this March with samples available for customers to try out the new taste.
お知らせ • May 18MusclePharm Corporation announced delayed 10-Q filingOn 05/17/2021, MusclePharm Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Jan 22Musclepharm Appoints Michael Heller to Its Board of DirectorsMusclePharm Corporation announced that it has appointed Michael Heller to its Board of Directors. Michael Heller, Principal of Talent Resources Holdings, is a marketing visionary in the world of influencer, celebrity, athlete and social media marketing. He has become a leading industry voice, having appeared in such major outlets as CNBC, Business Insider, Fortune, Fox Business, Buzzfeed, CNN, Digiday, The Hollywood Reporter, Vanity Fair and many others. With over 25 years of experience, Michael has conceived and produced some of the most high-profile events and activations in the country, including the annual Sports Illustrated Super Bowl party.
お知らせ • Jan 09William Bush Submits Resignation from the Board of Directors of MusclePharm Corporation and All CommitteesOn December 31, 2020, William Bush submitted his resignation from the Board of Directors of MusclePharm Corporation and all committees on which he served, effective the date thereof.